Research assessing transcriptome data, whole-exome sequencing data and DNA methylome profiling of 520 HCC patients demonstrated that AFP-high (serum concentration > 400 mg/L) tumors displayed significant activation of vascular endothelial growth factor (VEGF) signaling [61]. The gene discussed is VEGFA; the disease is hepatocellular carcinoma.